Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.

The analysis of the signal transduction inhibitor imatinib in patient tumour tissue using LC and MS/MS is described. The anticancer agent is eluted over RP-C18 within 2 mm together with its internal standard STI571-d8. Calibration curves were prepared in red blood cells (RBC). For quantitative isolation of the RBC, measurement of sediment was applied. There were no indications of signal suppression by substances originating in the biological matrix. The limit of determination in tumour tissue was in the range of those recorded for RBC and plasma. The assay is selective and sensitive, with its robustness favouring the experimental application in clinical oncology and its routine use in animal experiments. The LOD was 4.5 ng per gram in tumour tissue.

[1]  F. Tse,et al.  High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  H. Gschaidmeier,et al.  Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  M. Highley,et al.  Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatography. A.

[4]  A. Brandes,et al.  Current clinical management of gastrointestinal stromal tumors , 2004, Expert review of anticancer therapy.

[5]  J. Blay,et al.  Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. , 2005, European journal of cancer.

[6]  R. Maki.  Gastrointestinal stromal tumors respond to tyrosine kinase-targeted therapy , 2004, Current treatment options in gastroenterology.

[7]  T. Buclin,et al.  Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  M. Highley,et al.  The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment , 2004, Clinical chemistry and laboratory medicine.

[9]  F. Tse,et al.  Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[10]  S. Gupta,et al.  Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.